International Journal of Drug Policy
Volume 21, Issue 2 , Pages 125-128 , March 2010

Route transition interventions: Potential public health gains from reducing or preventing injecting

Received 30 September 2009 ,Revised 25 January 2010 ,Accepted 25 January 2010.

References 

  1. Aceijas C, Stimson GV, Hickman M, Rhodes T The United Nations Reference Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS. 2004;18:2295–2303
  2. AIDSMark . Regional lessons learned: eastern Europe. Washington DC: Population Services International; 2007;
  3. Barrio G, De La Fuente L, Royuela L, Díaz A, Rodríguez-Artalejo F The Spanish Group for the Study on the Route of Administration of Drugs. Cocaine use among heroin users in Spain: The diffusion of crack and cocaine smoking. Journal of Epidemiology and Community Health. 1998;52:172–180
  4. Bravo MJ, Barrio G, De La Fuente L, Royuela L, Domingo L, Silva T. Reasons for selecting an initial route of heroin administration and for subsequent transitions during a severe HIV epidemic. Addiction. 2003;98:749–760
  5. Brener, L., Spooner, C., Treloar, C. (2009). Preventing transitions to injecting among young people: What is the role of needle and syringe programmes? International Journal of Drug Policy, [Epub ahead of print].
  6. Cook C, Kanaef N. Global state of harm reduction 2008: Mapping the response to drug-related HIV and hepatitis C epidemics. London: International Harm Reduction Association; 2008;
  7. Darke S, Ross J. Fatal heroin overdoses resulting from non-injecting routes of administration, NSW, Australia, 1992–1996. Addiction. 2000;94:569–573
  8. De La Fuente L, Barrio G, Royuela L, Bravo MJ The Spanish Group for the Study on the Route of Heroin Administration. The transition from injecting to smoking heroin in three Spanish cities. Addiction. 1997;92:1749–1763
  9. Des Jarlais DC, Casriel C, Friedman SR, Rosenblum A. AIDS and the transition to illicit drug injection: Results of a randomized trial prevention program. Addiction. 1992;87:493–498
  10. Des Jarlais DC, Arasteh K, Perlis T, Hagan H, Heckathorn DD, McKnight C, et al. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City. Addiction. 2007;102:778–785
  11. Dewing S, Plüddemann A, Myers BJ, Parry CDH. Review of injection drug use in six African countries: Egypt, Kenya, Mauritius, Nigeria, South Africa and Tanzania. Drugs: Education, Prevention and Policy. 2006;13:121–137
  12. Dolan K, Clement N, Rouen D, Rees V, Shearer J, Wodak A. Can drug injectors be encouraged to adopt non-injecting routes of administration (NIROA) for drugs?. Drug and Alcohol Review. 2004;23:281–286
  13. Gartner CE, Hall W, Chapman S. Should the health community promote smokeless tobacco (snus) as a harm reduction measure?. PloS Medicine. 2007;7:1138–1141
  14. Gossop M, Stewart D, Marsden J, Kidd T, Strang J. Changes in route of drug administration among continuing heroin users: Outcomes 1 year after intake to treatment. Addictive Behaviors. 2004;29:1085–1094
  15. Grund JC. Drug use as a social ritual: functionality, symbolism and determinants of self-regulation. Rotterdam: Instituut voor Verslavingsonderzoek; 1993;
  16. Halligan E. Transitioning to injecting: What's it all about?. NUAA Users News. 2008;55:(Summer)
  17. Hunt N, Stillwell G, Taylor C, Griffiths P. Evaluation of a brief intervention to prevent initiation into injecting. Drugs: Education, Prevention and Policy. 1998;5:185–194
  18. Hunt N, Preston A, Stillwell G. A guide to assessing ‘route transitions’ and developing interventions that promote safer drug use. Dorchester: Exchange Supplies; 2005;
  19. Kools, J. (in press). The Dutch experience in promoting transition away from injecting drug use, 1991–2009. Dorchester: Exchange Supplies.
  20. Langendam MW, Van Brussel GHA, Coutinho RA, Van Ameijden EJC. Methadone maintenance and cessation of injecting drug use: Results from the Amsterdam cohort study. Addiction. 2000;95:591–600
  21. Leonard L, DeRubeis E, Pelude L, Medd E, Birkett N, Seto J. “I inject less as I have easier access to pipes”: Injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. International Journal of Drug Policy. 2008;19:255–264
  22. Matsumoto T, Kamijo A, Miyakawa T, Endo K, Yabana T, Kishimoto H, et al. Methamphetamine in Japan: The consequences of methamphetamine abuse as a function of route of administration. Addiction. 2002;97:809–817
  23. McNeill A, Bridge J. Seeing past the smoke. Drink and Drug News. 2007;(April 23):10–11
  24. Neaigus A, Gyarmathy VA, Miller M, Frajzyngier VM, Friedman SR, Des Jarlais DC. Transitions to injecting drug use among noninjecting heroin users: Social network influence and individual susceptibility. Journal of Acquired Immune Deficiency Syndrome. 2006;41:493–503
  25. Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D. Evidence for the effectiveness of harm reduction interventions in preventing hepatitis C transmission among injecting drug users: A review of reviews. In: Report for the Prevention Working Groups of the Advisory Council on the Misuse of Drugs and the Hepatitis C Action Plan for Scotland. 2009;
  26. Pizzey R, Hunt N. Distributing foil from needle and syringe programmes (NSPs) to promote transitions from heroin injecting to chasing: An evaluation. Harm Reduction Journal. 2008;5:24
  27. Robertson JR, Ronald PJM, Raab GM, Ross AJ, Parpia T. Deaths, HIV infection, abstinence, and other outcomes in a cohort of injecting drug users followed up for 10 years. British Medical Journal. 1994;309:369–372
  28. Scheinmann R, Hagan H, Lelutiu-Weinberger C, Stern R, Des Jarlais DC, Flom PL, et al. Non-injection drug use and hepatitis C virus: A systematic review. Drug and Alcohol Dependence. 2007;89:1–12
  29. Seanor D, Alcabes P, Drucker E. Tobacco harm reduction How rationale public policy could transform a pandemic. International Journal of Drug Policy. 2007;18:70–74
  30. Shannon K, Ishida T, Morgan R, Bear A, Oleson M, Kerr T, et al. Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users. Harm Reduction Journal. 2006;3:1
  31. Sibthorpe B, Lear B. Circumstances surrounding needle use transitions among injection drug users: Implications for HIV intervention. International Journal of the Addictions. 1994;29:1245–1257
  32. Southwell, M. (1997). “Up Your Bum”: A Simple, Safer Route of Drug Taking or a Squirt Too Far? Retrieved 29th September 2009 www.drugtext.org/library/articles/southwell02.htm.
  33. Southwell M. Transitions to and from injecting. In:  Pates R,  McBride A,  Arnold K editor. Injecting illicit drugs. Oxford: Blackwell Publishing Ltd.; 2005;p. 118–134
  34. Stimson GV. The global diffusion of injecting drug use: Implications for human immunodeficiency infection. Bulletin on Narcotics. 1993;45:3–12
  35. Stimson GV, Adelekan M, Rhodes T. The diffusion of drug injecting in developing countries. International Journal of Drug Policy. 1996;7:245–255
  36. Stimson GV, Choopanya K. Global perspectives on drug injecting. In:  Stimson GV,  Des Jarlais DC,  Ball A editor. Drug injecting and HIV infection: global dimensions and local responses. London: UCL Press; 1998;
  37. Strang J, Griffiths P, Powis B, Gossop M. First use of heroin: Changes in route of administration over time. British Medical Journal. 1992;304:1222–1223
  38. Strang J, Griffiths P, Powis B, Abbey J, Gossop M. How constant is an individual's route of heroin administration? Data from treatment and non-treatment samples. Drug and Alcohol Dependence. 1997;46:115–118
  39. Strang J, Bearn J, Farrell M, Finch E, Gossop M, Griffiths P, et al. Route of drug use and its implications for drug effect, risk of dependence and health consequences. Drug and Alcohol Review. 1998;17(2):197–211
  40. Van Ameijden EJC, Coutinho RA. Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS. 1998;12:625–633
  41. Van Ameijden EJC, Coutinho RA. Large decline in injecting drug use in Amsterdam, 1986–1998: Explanatory mechanisms and determinants of injecting transitions. Journal of Epidemiology and Community Health. 2001;55:356–363
  42. Van Beek I. The POTTI Project: What it's all about!. NUAA Users News. 2009;56:(Autumn)
  43. Witteveen EJ. Knowledge gained through experience in young problem drug users: reflections on interventions and change. Amsterdam: Universiteit van Amsterdam; 2008;

PII: S0955-3959(10)00012-5

doi: 10.1016/j.drugpo.2010.01.011

International Journal of Drug Policy
Volume 21, Issue 2 , Pages 125-128 , March 2010

Article Tools